Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Mechanism of action: Activates both GLP-1 receptors AND GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously GIP receptors in fat tissue directly regulate lipid metabolism and fat cell energy storage Dual activation creates a synergistic effect on appetite suppression and energy expenditure Produces stronger improvement in insulin sensitivity compared to GLP-1-only medications FDA-approved brand names: Zepbound approved for chronic weight management Mounjaro approved for type 2 diabetes Why does the dual mechanism matter
Six months represents the minimum for meaningful results, but 12 months or longer produces significantly better outcomes
Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue
Nausea, particularly in the first few weeks after starting or increasing your dose, affects many patients but typically resolves as your body adjusts
It influences upstream biological conditions that regulate natural GLP-1 secretion: SCFA-mediated receptor activation (FFAR2/3) Mucosal barrier stability Reduced inflammatory tone Improved enteroendocrine cell signaling GLP-1 is a hormone
Once it has been injected, the semaglutide binds to the GLP-1 receptor and activates it to increase insulin secretion
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
